| Accession Number | 0002113721-26-000014 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 21, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CEO, Diagnostics | Class A Common Stock | โ | Aug 18, 2026 | Sale | 9,232 | $49.61 | $457,999.52 | 97,797 | Direct | โ | View Details | |
CEO, Diagnostics | Class A Common Stock | โ | Aug 19, 2026 | Sale | 3,094 | $55.97 | $173,171.18 | 94,703 | Direct | โ | View Details | |
CEO, Diagnostics | Class A Common Stock | โ | Aug 19, 2026 | Sale | 100 | $56.47 | $5,647.00 | 94,603 | Direct | โ | View Details | |
CEO, Diagnostics | Class A Common Stock | โ | Aug 19, 2026 | Sale | 500 | $57.94 | $28,970.00 | 94,103 | Direct | โ | View Details | |
CEO, Diagnostics | Class A Common Stock | โ | Aug 19, 2026 | Sale | 2,994 | $59.97 | $179,550.18 | 91,109 | Direct | โ | View Details | |
CEO, Diagnostics | Class A Common Stock | โ | Aug 19, 2026 | Sale | 900 | $60.45 | $54,405.00 | 90,209 | Direct | โ | View Details | |
CEO, Diagnostics | Class A Common Stock | โ | Aug 19, 2026 | Sale | 494 | $61.23 | $30,247.62 | 89,715 | Direct | โ | View Details |